Physicochemical Properties
| Molecular Formula | C23H27N3O6S |
| Molecular Weight | 473.541984796524 |
| Exact Mass | 473.162 |
| CAS # | 152684-53-2 |
| Related CAS # | Ezatiostat;168682-53-9 |
| PubChem CID | 444051 |
| Appearance | White to off-white solid powder |
| LogP | -0.9 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 13 |
| Heavy Atom Count | 33 |
| Complexity | 665 |
| Defined Atom Stereocenter Count | 3 |
| SMILES | [C@@H](C1C=CC=CC=1)(C(=O)O)NC(=O)[C@H](CSCC1C=CC=CC=1)NC(=O)CC[C@H](N)C(=O)O |
| InChi Key | ZPSKWMFLCHMEOY-CMKODMSKSA-N |
| InChi Code | InChI=1S/C23H27N3O6S/c24-17(22(29)30)11-12-19(27)25-18(14-33-13-15-7-3-1-4-8-15)21(28)26-20(23(31)32)16-9-5-2-6-10-16/h1-10,17-18,20H,11-14,24H2,(H,25,27)(H,26,28)(H,29,30)(H,31,32)/t17-,18-,20+/m0/s1 |
| Chemical Name | (2S)-2-amino-5-[[(2R)-3-benzylsulfanyl-1-[[(R)-carboxy(phenyl)methyl]amino]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | Ki: 0.4 μM[1], 0.56 μM (glyoxalase I)[2] |
| ln Vitro | With a binding affinity greater than GSH and a selectivity for GSTP that is over 50 times greater than that of the GSTM and GSTA classes (Ki=0.4 μM), TLK117 is the most specific GSTP inhibitor found to date[1]. TER 117 is a GST P1-1 isoenzyme inhibitor designed to avoid the known role of GST P1-1 in tumor cells' resistance to drugs. TER 117 is administered as a diethyl ester (TER 117 DEE, also known as TER 199) to aid in its cellular uptake. It has been discovered that TER 117 is a competitive inhibitor of glyoxalase I and GST P1-1[2]. |
| ln Vivo | When the GSTP inhibitor TLK117 is administered orally during the pharyngeal stage of fibrosis, it reduces the amount of remodeling caused by bleomycin and AdTGFβ, α-SMA, caspase activation, FAS S-glutathionylation, and total protein S-glutathionylation. GSTP activity is significantly reduced four hours after the administration of 50 mg/kg TLK117, and it stays reduced by roughly 60% for at least twenty-four hours[2]. |
| References |
[1]. The human glutathione transferase P1-1 specific inhibitor TER 117 designed for overcomingcytostatic-drug resistance is also a strong inhibitor of glyoxalase I. Mol Pharmacol. 2000 Mar;57(3):619-24. [2]. Attenuation of lung fibrosis in mice with a clinically relevant inhibitor of glutathione-S-transferase π. JCI Insight. 2016 Jun 2;1(8). pii: e85717. |
| Additional Infomation | See also: ... View More ... |
Solubility Data
| Solubility (In Vitro) | DMSO: 150 mg/mL (316.76 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (5.28 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (5.28 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (5.28 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.1118 mL | 10.5588 mL | 21.1175 mL | |
| 5 mM | 0.4224 mL | 2.1118 mL | 4.2235 mL | |
| 10 mM | 0.2112 mL | 1.0559 mL | 2.1118 mL |